T. Rowe Price Associates
VICR icon

T. Rowe Price Associates’s Vicor VICR Stock Holding History

T. Rowe Price Associates’s Portfolio VICR Stock Details VICR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$304M Buy
1,888,446
+1,448,626
+329% +$239M 0.04% 357
2025
Q4 		$48.2M Buy
439,820
+413,038
+1,542% +$35.1M 0.01% 825
2025
Q3 		$1.33M Buy
26,782
+1,056
+4% +$51.4K ﹤0.01% 1934
2025
Q2 		$1.17M Buy
25,726
+1,517
+6% +$67.8K ﹤0.01% 1920
2025
Q1 		$1.13M Buy
24,209
+1,031
+4% +$54.6K ﹤0.01% 1893
2024
Q4 		$1.12M Buy
23,178
+1,475
+7% +$73.7K ﹤0.01% 1918
2024
Q3 		$914K Buy
21,703
+349
+2% +$13K ﹤0.01% 2009
2024
Q2 		$709K Buy
21,354
+2,125
+11% +$73.3K ﹤0.01% 2043
2024
Q1 		$736K Buy
19,229
+2,535
+15% +$98.5K ﹤0.01% 2042
2023
Q4 		$751K Buy
16,694
+1,344
+9% +$59.2K ﹤0.01% 2002
2023
Q3 		$904K Buy
15,350
+4,207
+38% +$279K ﹤0.01% 1845
2023
Q2 		$602K Buy
11,143
+204
+2% +$10.1K ﹤0.01% 2039
2023
Q1 		$514K Buy
10,939
+152
+1% +$8.43K ﹤0.01% 2093
2022
Q4 		$580K Buy
10,787
+978
+10% +$51.4K ﹤0.01% 2068
2022
Q3 		$581K Buy
9,809
+1,457
+17% +$96.2K ﹤0.01% 2052
2022
Q2 		$457K Buy
8,352
+212
+3% +$13.1K ﹤0.01% 2256
2022
Q1 		$574K Buy
8,140
+434
+6% +$39K ﹤0.01% 2275
2021
Q4 		$979K Sell
7,706
-760
-9% -$108K ﹤0.01% 2055
2021
Q3 		$1.14M Sell
8,466
-5,310
-39% -$634K ﹤0.01% 1995
2021
Q2 		$1.46M Sell
13,776
-1,605
-10% -$143K ﹤0.01% 1881
2021
Q1 		$1.31M Buy
15,381
+117
+0.8% +$11K ﹤0.01% 1915
2020
Q4 		$1.41M Buy
15,264
+401
+3% +$33.7K ﹤0.01% 1781
2020
Q3 		$1.16M Sell
14,863
-509
-3% -$40.5K ﹤0.01% 1736
2020
Q2 		$1.11M Sell
15,372
-44
-0.3% -$2.47K ﹤0.01% 1740
2020
Q1 		$687K Buy
15,416
+141
+0.9% +$6.69K ﹤0.01% 1846
2019
Q4 		$714K Sell
15,275
-4,692
-23% -$179K ﹤0.01% 2026
2019
Q3 		$589K Buy
19,967
+146
+0.7% +$4.5K ﹤0.01% 2034
2019
Q2 		$615K Hold
19,821
– – ﹤0.01% 2031
2019
Q1 		$615K Sell
19,821
-4,010
-17% -$148K ﹤0.01% 2044
2018
Q4 		$901K Buy
23,831
+12,741
+115% +$465K ﹤0.01% 1839
2018
Q3 		$510K Buy
11,090
+194
+2% +$10.7K ﹤0.01% 2145
2018
Q2 		$475K Buy
10,896
+18
+0.2% +$696 ﹤0.01% 2161
2018
Q1 		$311K Buy
10,878
+33
+0.3% +$709 ﹤0.01% 2282
2017
Q4 		$227K Hold
10,845
– – ﹤0.01% 2383
2017
Q3 		$256K Hold
10,845
– – ﹤0.01% 2328
2017
Q2 		$194K Hold
10,845
– – ﹤0.01% 2391
2017
Q1 		$175K Hold
10,845
– – ﹤0.01% 2421
2016
Q4 		$164K Hold
10,845
– – ﹤0.01% 2412
2016
Q3 		$126K Sell
10,845
-7,055
-39% -$76.3K ﹤0.01% 2418
2016
Q2 		$180K Hold
17,900
– – ﹤0.01% 2352
2016
Q1 		$188K Hold
17,900
– – ﹤0.01% 2303
2015
Q4 		$163K Hold
17,900
– – ﹤0.01% 2346
2015
Q3 		$183K Hold
17,900
– – ﹤0.01% 2312
2015
Q2 		$218K Hold
17,900
– – ﹤0.01% 2318
2015
Q1 		$272K Buy
17,900
+1,500
+9% +$19.4K ﹤0.01% 2234
2014
Q4 		$198K Hold
16,400
– – ﹤0.01% 2364
2014
Q3 		$154K Hold
16,400
– – ﹤0.01% 2402
2014
Q2 		$137K Buy
16,400
+800
+5% +$6.49K ﹤0.01% 2434
2014
Q1 		$159K Hold
15,600
– – ﹤0.01% 2373
2013
Q4 		$209K Hold
15,600
– – ﹤0.01% 2301
2013
Q3 		$128K Buy
15,600
+1,500
+11% +$12K ﹤0.01% 2358
2013
Q2 		$97K Buy
+14,100
New +$75.7K ﹤0.01% 2345

Other funds holding VICR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates's VICR Position: Q1 2026 in Review

T. Rowe Price Associates increased its Vicor (VICR) stake by 329% in Q1 2026, buying an estimated $239M and bringing the position to 1,888,446 shares worth $304M. The position accounts for 0.04% of the portfolio, ranked #357.

T. Rowe Price Associates first reported a position in VICR in Q2 2013 and has held it in 52 quarters since. 369 funds tracked by Wall St. Rank hold VICR as of Q1 2026.

  • T. Rowe Price Associates held 1,888,446 shares of Vicor worth $304M as of Q1 2026.
  • T. Rowe Price Associates bought 1,448,626 Vicor shares in Q1 2026, an estimated $239M.
  • Vicor made up 0.04% of T. Rowe Price Associates's portfolio in Q1 2026, its #357 holding.
  • T. Rowe Price Associates first reported a position in Vicor in Q2 2013 and has held it in 52 quarters since.
  • 369 funds tracked by Wall St. Rank held Vicor as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.